NCT03362788View on ClinicalTrials.gov

The Greek AntiPlatElet Atrial Fibrillation Registry.

CompletedOBSERVATIONAL
Enrollment

654

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Atrial FibrillationCoronary Artery Disease
Interventions
DRUG

VKA

VKA plus a P2Y12 inhibitor (clopidogrel 75mg or ticagrelor 90mg twice daily) and/or aspirin ≤100mg daily.

DRUG

NOAC

NOAC plus a P2Y12 inhibitor (clopidogrel 75mg or ticagrelor 90mg twice daily) and/or aspirin ≤100mg daily.

Trial Locations (1)

12462

Attikon University Hospital, Athens

All Listed Sponsors
collaborator

Hellenic Cardiology Society

OTHER

lead

Attikon Hospital

OTHER

NCT03362788 - The Greek AntiPlatElet Atrial Fibrillation Registry. | Biotech Hunter | Biotech Hunter